CASSAVA SCIENCES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.19 USD | -0.38% |
|
-18.84% | -5.86% |
Chart calendar Cassava Sciences, Inc.
e8.Qdomp1EZv8maKVBjSS7YCvKl8_mF-BLsFB-F1e2n8eY.LrVo7D9Wy_nFQWYZDV60TpCVopLDtX3cUi3dkYLqgZURvWHDByHV8dgQGQ~e0f507c905c0f707a9014c1ba970aab4
Upcoming events on Cassava Sciences, Inc.
Past events on Cassava Sciences, Inc.
| 2024-03-05 08:00 am | Alzheimer and Parkinson Diseases International Conference |
| 2024-02-28 09:14 am | Q4 2023 Earnings Release |
| 2023-11-07 09:01 am | Q3 2023 Earnings Release |
| 2023-10-27 03:30 pm | Clinical Trials on Alzheimer Disease Conference |
| 2023-10-11 10:30 am | Jefferies Inaugural Biotech CNS/Neuro Summit |
| 2023-10-09 | JonesTrading Healthcare Summit |
| 2023-09-10 | H.C. Wainwright Global Investment Conference |
| 2023-09-10 | Morgan Stanley Global Healthcare Conference |
| 2023-08-03 09:07 am | Q2 2023 Earnings Release |
| 2023-06-08 04:30 pm | Jefferies Global Healthcare Conference |
| 2023-05-14 | European Society of Endocrinology Congress |
| 2023-05-04 11:00 am | Annual General Meeting |
| 2023-05-02 03:00 pm | H.C. Wainwright BioConnect Investor Conference |
| 2023-05-01 09:00 am | Q1 2023 Earnings Release |
| 2023-02-28 09:15 am | Q4 2022 Earnings Release |
| 2022-11-07 09:00 am | Q3 2022 Earnings Release |
| 2022-09-13 03:30 pm | H.C. Wainwright Global Investment Conference |
| 2022-08-02 | Interim 2022 Earnings Release |
| 2022-05-05 11:00 am | Annual General Meeting |
| 2022-05-05 09:00 am | Q1 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -4,96 -5,67 12.49% | -6,45 -5,37 -20.01% | -32,9 -32,7 -0.61% | -80,0 -82,6 3.06% | -106 -100 -5.53% | -100 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -4,63 -5,33 13.16% | -6,33 -5,27 -20.26% | -32,4 -32,5 0.24% | -76,2 -80,4 5.17% | -97,2 -93,0 -4.53% | -92,9 |
|
Net income Million USD | Released Forecast Spread | -4,63 -5,33 13.16% | -6,33 -5,27 -20.26% | -32,4 -32,5 0.24% | -76,2 -80,4 5.17% | -97,2 -93,0 -4.53% | -92,9 |
|
EPS USD | Released Forecast Spread | -0,27 -0,31 12.9% | -0,24 -0,20 -22.03% | -0,82 -0,82 0.4% | -1,90 -2,01 5.24% | -2,32 -2,22 -4.5% | -2,01 |
| Announcement Date | 26/03/20 | 23/03/21 | 28/02/22 | 28/02/23 | 28/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -14,4 -14,2 -1.53% | -17,8 -17,2 -3.87% | -19,9 -19,6 -1.62% | -21,3 -20,4 -4.79% | -20,9 -23,5 10.91% | -26,5 -23,4 -13.3% | -28,8 -24,7 -16.51% | -27,9 -38,0 26.63% | -22,8 -17,2 -32.49% | -23,8 | -22,8 | -25,3 | -28,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -14,2 -14,2 0.38% | -17,5 -16,7 -5.27% | -19,3 -19,6 1.39% | -20,3 -23,6 14.17% | -19,1 -23,3 17.7% | -24,3 -23,1 -5.07% | -26,4 -24,1 -9.44% | -25,7 -37,5 31.6% | -20,9 -16,7 -25.26% | -22,0 | -20,9 | -23,4 | -26,5 |
|
Net income Million USD | Released Forecast Spread | -14,2 -14,2 0.38% | -17,5 -17,2 -2.16% | -19,3 -19,6 1.39% | -20,3 -20,4 0.55% | -19,1 -23,3 17.7% | -24,3 -23,1 -5.07% | -26,4 -24,1 -9.44% | -25,7 -37,5 31.6% | -20,9 -16,7 -25.26% | -22,0 | -20,9 | -23,4 | -26,5 |
|
EPS USD | Released Forecast Spread | -0,35 -0,35 0.94% | -0,44 -0,43 -3.12% | -0,48 -0,49 2.04% | -0,51 -0,51 0% | -0,47 -0,58 18.97% | -0,58 -0,56 -3.57% | -0,63 -0,58 -8.62% | -0,61 -0,90 32.22% | -0,50 -0,40 -25% | -0,51 | -0,48 | -0,54 | -0,48 |
| Announcement Date | 28/02/22 | 05/05/22 | 04/08/22 | 07/11/22 | 28/02/23 | 01/05/23 | 03/08/23 | 07/11/23 | 28/02/24 | - | - | - | - |
More events
Past sector events for Cassava Sciences, Inc.
| 2024-04-17 | BEIJING KAWIN TECHNOLOGY SHARE-HOLDING CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-04-17 | JIANGSU YAHONG MEDITECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-12 | SINOCELLTECH GROUP LIMITED: Q4 2023 Earnings Release |
| 2024-04-10 07:00 am | NURIX THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-04-08 | MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-02 03:06 am | TAIMED BIOLOGICS INC.: March 2024 Sales and Revenue Release |
| 2024-03-31 | PEPTRON, INC.: Q4 2023 Earnings Release (Projected) |
| 2024-03-31 | BIONEER CORPORATION: Q4 2023 Earnings Release (Projected) |
| 2024-03-29 08:30 am | INNOCARE PHARMA LIMITED: Q4 2023 Earnings Release |
| 2024-03-28 | BIO-THERA SOLUTIONS, LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SAVA Stock
- Calendar Cassava Sciences, Inc.
